Kestra Advisory Services, LLC Jazz Pharmaceuticals PLC Transaction History

Kestra Advisory Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	BUY	$129.72 - $159.85 $87,431 - $107,738	674 Added 31.39%	2,821 $449,000
Q3 2022 Nov 01, 2022	SELL	$126.59 - $161.18 $109,880 - $139,904	-868 Reduced 28.79%	2,147 $286 Million
Q2 2022 Aug 12, 2022	BUY	$141.59 - $168.66 $86,086 - $102,545	608 Added 25.26%	3,015 $470,000
Q1 2022 Apr 26, 2022	BUY	$129.64 - $160.7 $3,370 - $4,178	26 Added 1.09%	2,407 $374,000
Q4 2021 Jan 20, 2022	SELL	$119.87 - $145.67 $85,587 - $104,008	-714 Reduced 23.07%	2,381 $303,000
Q3 2021 Oct 19, 2021	BUY	$128.64 - $184.79 $11,963 - $17,185	93 Added 3.1%	3,095 $402,000
Q2 2021 Jul 28, 2021	BUY	$160.2 - $186.42 $480,920 - $559,632	3,002 New	3,002 $533,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.